explore -WSS

explore

author：fashion 2025-09-06 03:33:44 - browse：7

HIV/AIDS Drugs — Joe Raedle/Getty Images

Couples in which one partner is HIV-positive have a low risk of transmitting the disease if the infected partner is on antiretroviral drugs, a new study found, even if they are not using condoms.

Why it matters:

Scientist have been studying for decades whether HIV-positive individuals who take certain combinations of drugs, called antiretroviral therapy (ART), will infect their partners with the virus. A landmark study, which mostly enrolled heterosexual couples, found that ART taken by infected individuals reduced the risk of HIV transmission by 96 percent.

But many of the people in that study also wore condoms, which can help prevent HIV. So it remained unclear how effective the drugs are on their own, and whether the results also applied in homosexual couples.

The nitty gritty:

Over an average of 1.3 years, researchers followed 888 couples in which the infected partner was taking ART. About one third of the couples were men who had sex with men — a group for which less data on the effectiveness of ART had been available. The researchers found no transmission of HIV to the uninfected partner during the study.

Related: An AIDS-free world is possible, but do we have the will to achieve it?

The study was purely observational, following couples who were already receiving ART and who did not plan on using condoms. Participants were recommended, at each of their visits, to use condoms during sex, and were given information about other drugs they could take to minimize their chances of acquiring HIV. The findings were published Tuesday in the Journal of the American Medical Association.

But keep in mind:

The small sample size for some categories — for example, only 60 heterosexual men engaged in anal sex — means that some types of sex had less robust evidence than others.

The research is ongoing, said Dr. Alison Rodger, first author on the new study and a professor of infectious diseases at University College London. The team is trying to recruit more gay men so that they can improve the precision of their estimates of HIV transmission risk.

The bottom line:

This study adds further weight to the evidence that suppressive ART is very effective at preventing HIV transmission if it’s used diligently.

Newsletters

Sign up for Daily Recap

A roundup of STAT's top stories of the day.

Please enter a valid email address. Privacy Policy

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Readout Newsletter: Bayer study halts, Carmot to IPO, and more

hotspot

WSS

South Korea throws huge K

Astellas still sees hope in its gene therapy after four deaths

Why medical students are struggling with mental health

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Anthos stroke drug appears safer than common blood thinner

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

explore

explore

Why it matters:

The nitty gritty:

Related: An AIDS-free world is possible, but do we have the will to achieve it?

But keep in mind:

The bottom line:

Sign up for Daily Recap

leisure time

Duchenne breakthrough therapy leaves behind pioneering families

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Psychedelics group wrestles with new pharma identity

Readout LOUD podcast: A CRISPR milestone, biotech mixology

The cancer drug shortage isn’t new — and neither are the solutions

NIH trials fail to test meaningful long Covid therapies, experts say

Medicare proposal to cover medical devices draws a mixed reaction

Maui's cultural, historic landmarks damaged in the devastating wildfires

Anesthesiologist group: stop taking Ozempic before surgery

Why failed clinical trials don’t always spell doom for a new drug

focus

Poor hospice wound care hurts patients and families

In same hospitals, Black patients receive fewer opioids than white patients

Why failed clinical trials don’t always spell doom for a new drug

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

leisure time

hotspot

leisure time

hotspot